Dyne Therapeutics, Inc. SEC filings DYN
Dyne Therapeutics, Inc. has 796 filings in SEC EDGAR's recent list, going back to Jul 23, 2020. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Jul 22, 2026 | — |
| 424B5 | Prospectus supplement | Jul 21, 2026 | — |
| S-8 | Employee stock plan registration | Mar 27, 2026 | — |
| S-8 | Employee stock plan registration | Mar 2, 2026 | — |
| 424B5 | Prospectus supplement | Dec 10, 2025 | — |
| 424B5 | Prospectus supplement | Dec 8, 2025 | — |
| 424B5 | Prospectus supplement | Jul 1, 2025 | — |
| 424B5 | Prospectus supplement | Jun 30, 2025 | — |
| S-8 | Employee stock plan registration | Mar 27, 2025 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2024 | — |
| 424B5 | Prospectus supplement | May 22, 2024 | — |
| 424B5 | Prospectus supplement | May 20, 2024 | — |
| S-8 | Employee stock plan registration | May 2, 2024 | — |
| S-3ASR | Automatic shelf registration | Mar 5, 2024 | — |
| S-8 | Employee stock plan registration | Mar 5, 2024 | — |
| 424B5 | Prospectus supplement | Jan 5, 2024 | — |
| S-3MEF | Filing | Jan 4, 2024 | — |
| 424B5 | Prospectus supplement | Jan 3, 2024 | — |
| S-8 | Employee stock plan registration | Mar 2, 2023 | — |
| S-8 | Employee stock plan registration | Mar 10, 2022 | — |
| S-3 | Shelf registration | Nov 4, 2021 | — |
| S-8 | Employee stock plan registration | Mar 4, 2021 | — |
| 424B4 | Prospectus | Jan 21, 2021 | — |
| S-1MEF | Filing | Jan 20, 2021 | — |
| S-1 | Registration statement | Jan 19, 2021 | — |
| 424B4 | Prospectus | Sep 17, 2020 | — |
| S-8 | Employee stock plan registration | Sep 17, 2020 | — |
| S-1MEF | Filing | Sep 16, 2020 | — |
| S-1/A | Amended registration statement | Sep 10, 2020 | — |
| S-1 | Registration statement | Aug 25, 2020 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DYN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1818794
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.